Thai Pharma Company to Manufacture Three New Drugs for Complicated Ailments
Thai pharmaceutical company Siam Bioscience Group confirmed with the Bangkok Post that by 2022 the company plans to produce and sell three new drugs for cancer, kidney failure, and autoimmune diseases, both in Thailand and abroad. Established in 2009, Siam Bioscience...
German companies Looking at Vietnam’s Healthcare Sector
With the EU-Vietnam Free Trade Agreement (EVFTA) expected to come into effect in July 2020, German healthcare multinationals and SMEs operating in Medical technology, pharmaceuticals, and biotechnology are expressing a growing interest in the Vietnamese healthcare...
Indonesia Planning to Relax Drug Patent Rules to Boost Domestic Pharmaceutical Industry
The Indonesian federal government is planning to relax standards on drug patents with an omnibus bill on job creation to support the country’s pharmaceutical manufacturers and encourage patent-sharing. The government aims to strengthen the...